Drivers for Healthcare R&D Investment in Asia-Pacific
Investment in Research and Development (R&D) is the key to sustaining innovation and promoting growth in the healthcare industry. This report broadly tracks the events and crucial reasons that have transformed the APAC region into a preferred R&D investment destination. We highlight four countries—China, Singapore, South Korea, and Taiwan—which showed the highest increase in R&D investment between 2009 and 2012. Driven by healthcare market growth in the region, these countries have emerged as hotspots for R&D investment as a result of improved Intellectual Property (IP) regimes, governments’ promotions and incentives, and increased research capabilities.
Learn how to effectively navigate the market research process to help guide your organization on the journey to success.Download eBook